You can complete this program at your own pace, whenever and wherever you choose. Compliments of the ADA, this program is available online for FREE in 3 convenient formats:
Downloadable PDF.
Web-based interactive version.
Print version. (limited copies available)
Target Audience
This program is designed for physicians, physician assistants, registered
nurses, nurse practitioners, pharmacists, dieticians, certified diabetes educators
and other healthcare professionals who care for patients with diabetes and who
manage the complications related to the disease.
Learning Objectives
Discuss the incretin system: science and applications.
Apply the incretin hormone therapeutics: DPP-4.
Apply the incretin hormone therapeutics: GLP-1 analogs.
Evaluate and apply traditional therapies for type 2 diabetes, including thiazolidinediones, biguanides, alpha-glucosidase inhibitors, colesevelam, ranolizine, meglitinides, sulfonylureas.
Evaluate and apply insulin use for the management of type 2 diabetes: high-risk patient, hospitalized patient, outgoing management, dosing.
The estimated time for completion of this activity is 5 hours.
These continuing education activities were planned and produced
in accordance with all accrediting board standards.
Release Date: November 1, 2010 Credit Expiration Date: October 31, 2012
Commercial Support
This program is supported by unrestricted educational grants from Amylin Pharmaceuticals, Inc. and Lilly USA, Inc.; Bristol-Myers Squibb and AstraZeneca LP; Merck; Merck Schering/Plough Pharmaceuticals; and Roche Laboratories, Inc.
Email this page
